205 related articles for article (PubMed ID: 24418540)
1. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
[TBL] [Abstract][Full Text] [Related]
2. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
[TBL] [Abstract][Full Text] [Related]
3. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
[TBL] [Abstract][Full Text] [Related]
4. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
5. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
6. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.
Hultquist JF; Binka M; LaRue RS; Simon V; Harris RS
J Virol; 2012 Mar; 86(5):2874-7. PubMed ID: 22205746
[TBL] [Abstract][Full Text] [Related]
7. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.
Hultquist JF; McDougle RM; Anderson BD; Harris RS
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1543-51. PubMed ID: 22725134
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X; Evans SL; Han X; Liu Y; Yu XF
PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
[TBL] [Abstract][Full Text] [Related]
9. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
[TBL] [Abstract][Full Text] [Related]
11. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
Ai Y; Ma J
Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
[TBL] [Abstract][Full Text] [Related]
12. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
13. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
Kim DY; Kwon E; Hartley PD; Crosby DC; Mann S; Krogan NJ; Gross JD
Mol Cell; 2013 Feb; 49(4):632-44. PubMed ID: 23333304
[TBL] [Abstract][Full Text] [Related]
14. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
[TBL] [Abstract][Full Text] [Related]
15. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Wang X; York IA; Zheng YH
J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
[TBL] [Abstract][Full Text] [Related]
16. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M; Ooms M; Steward M; Simon V
J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
[TBL] [Abstract][Full Text] [Related]
17. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.
Hu Y; Knecht KM; Shen Q; Xiong Y
FEBS J; 2021 Jun; 288(11):3407-3417. PubMed ID: 32893454
[TBL] [Abstract][Full Text] [Related]
19. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
20. CBFß and HIV Infection.
Kim DY; Gross JD
Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
